Medilia Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 28-10-2024
- Paid Up Capital ₹ 3.00 Cr
as on 28-10-2024
- Company Age 3 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 99.00 Cr
as on 28-10-2024
- Revenue -52.78%
(FY 2023)
- Profit 44.44%
(FY 2023)
- Ebitda 64.78%
(FY 2023)
- Net Worth -1.81%
(FY 2023)
- Total Assets 3.78%
(FY 2023)
About Medilia
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 3.00 Cr.
The company currently has active open charges totaling ₹99.00 Cr.
Akshay Gupta, Harish Goyal, Amarjyot Anand, and Three other members serve as directors at the Company.
- CIN/LLPIN
U24299DL2021PLC381855
- Company No.
381855
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
03 Jun 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Medilia?
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pratik Gupta  | Additional Director | 01-May-2024 | Current |
| Akshay Gupta | Additional Director | 06-Jun-2024 | Current |
| Harish Goyal | Director | 03-Jun-2021 | Current |
| Amarjyot Anand | Additional Director | 01-May-2024 | Current |
| Gaurav Rajput | Director | 08-Dec-2021 | Current |
| Anant Aggarwal | Director | 08-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Medilia.
Medilia Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 52.78% decrease. The company also saw a substantial improvement in profitability, with a 44.44% increase in profit. The company's net worth dipped by a decrease of 1.81%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medilia?
In 2023, Medilia had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Yashash Commodities Private LimitedActive 26 years 9 monthsAkshay Gupta and Pratik Gupta are mutual person
Divyadhan Recycling Industries Private LimitedActive 14 years 7 monthsPratik Gupta is a mutual person
- Sonpankhi Shares And Securities Private LimitedActive 30 years 5 months
Akshay Gupta is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Jul 2024 | ₹99.00 Cr | Open |
How Many Employees Work at Medilia?
Medilia has a workforce of 0 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medilia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medilia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
